127 related articles for article (PubMed ID: 1757568)
1. Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin.
Jones RN; Erwin ME
J Clin Microbiol; 1991 Dec; 29(12):2890-2. PubMed ID: 1757568
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
Erwin ME; Jones RN; Barrett MS; Briggs BM; Johnson DM
Antimicrob Agents Chemother; 1991 May; 35(5):929-37. PubMed ID: 1854174
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.
Washington JA; Jones RN; Allen SD; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Erwin ME
Antimicrob Agents Chemother; 1991 Jul; 35(7):1508-11. PubMed ID: 1929319
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of a catechol-substituted cephalosporin, GR69153.
Wise R; Andrews JM; Ashby JP; Thornber D
Antimicrob Agents Chemother; 1991 Feb; 35(2):329-34. PubMed ID: 2024966
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
Fuchs PC; Jones RN; Barry AL
Antimicrob Agents Chemother; 1990 May; 34(5):914-7. PubMed ID: 2193626
[TBL] [Abstract][Full Text] [Related]
6. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
Jones RN; Erwin ME; Gooding BB
J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
[TBL] [Abstract][Full Text] [Related]
8. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
Jones RN; Erwin ME
J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
Chin NX; Gu JW; Fang W; Neu HC
Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
[TBL] [Abstract][Full Text] [Related]
10. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
[TBL] [Abstract][Full Text] [Related]
11. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
13. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
[TBL] [Abstract][Full Text] [Related]
14. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
[TBL] [Abstract][Full Text] [Related]
15. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.
Jones RN; Erwin ME; Barrett MS
Diagn Microbiol Infect Dis; 1992; 15(4):379-81. PubMed ID: 1319303
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disks.
Jones RN; Thornsberry C; Barry AL
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):87-92. PubMed ID: 3967476
[TBL] [Abstract][Full Text] [Related]
17. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
[TBL] [Abstract][Full Text] [Related]
18. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
19. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
[TBL] [Abstract][Full Text] [Related]
20. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
Jones RN; Barry AL
J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
